- Filed
- Feb 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 6, 2026 | 61.19M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 61.11M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 61.1M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 60.55M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 60.42M sh |
| Capex | Q3 2026 · Dec 31, 2025 | $175.77M |
| Capex | Q3 2026 · Dec 31, 2024 | $53.58M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | $1.73B |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | $343.31M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $869.17M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $837.3M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2024 | $577.94M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $1.39B |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $1.21B |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $10.98B |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $8.7B |
| Total Assets | Q3 2026 · Dec 31, 2025 | $12.38B |
| Total Assets | Q3 2026 · Mar 31, 2025 | $9.91B |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $1.25 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $2.38 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $1.29 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $3.76 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $1.27 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $2.43 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $1.32 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $3.83 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $71.42M |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $158.95M |
| Sga Expense restated | Q3 2026 · Dec 31, 2024 | $53.87M |
| Sga Expense restated | Q3 2026 · Dec 31, 2024 | $135.14M |
| Net Income | Q3 2026 · Dec 31, 2025 | $76.24M |
| Net Income | Q3 2026 · Dec 31, 2025 | $145.35M |
| Net Income | Q3 2026 · Dec 31, 2024 | $78.28M |
| Net Income | Q3 2026 · Dec 31, 2024 | $227.34M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $25.35M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $54.39M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $9.39M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $18.91M |
| Revenue | Q3 2026 · Dec 31, 2025 | $628.62M |
| Revenue | Q3 2026 · Dec 31, 2025 | $1.69B |
| Revenue restated | Q3 2026 · Dec 31, 2024 | $664.58M |
| Revenue restated | Q3 2026 · Dec 31, 2024 | $1.71B |